These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 18637607)
1. Tachyphylaxis to cisatracurium--case reports and literature review. Haddad S Middle East J Anaesthesiol; 2008 Jun; 19(5):1079-92. PubMed ID: 18637607 [TBL] [Abstract][Full Text] [Related]
2. A retrospective analysis of long-term use of nondepolarizing neuromuscular blocking agents in the intensive care unit, and guidelines for drug selection. Clarens DM; Kelly KJ; Gilliland SS; Kohls PK; Nahum A; Vance-Bryan K Pharmacotherapy; 1993; 13(6):647-55. PubMed ID: 7905621 [TBL] [Abstract][Full Text] [Related]
4. Prolonged weakness after cisatracurium infusion: a case report. Davis NA; Rodgers JE; Gonzalez ER; Fowler AA Crit Care Med; 1998 Jul; 26(7):1290-2. PubMed ID: 9671384 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Cisatracurium Versus Atracurium in Early ARDS. Moore L; Kramer CJ; Delcoix-Lopes S; Modrykamien AM Respir Care; 2017 Jul; 62(7):947-952. PubMed ID: 28351905 [TBL] [Abstract][Full Text] [Related]
6. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults. Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347 [TBL] [Abstract][Full Text] [Related]
7. A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients. Newman PJ; Quinn AC; Grounds RM; Hunter JM; Boyd AH; Eastwood NB; Pollard BJ; Pearson AJ; Harper NJ; Beale RJ; Sutjarittam M; Elliot JM; Bion JF Crit Care Med; 1997 Jul; 25(7):1139-42. PubMed ID: 9233738 [TBL] [Abstract][Full Text] [Related]
8. An Observational Study of the Efficacy of Cisatracurium Compared with Vecuronium in Patients with or at Risk for Acute Respiratory Distress Syndrome. Sottile PD; Kiser TH; Burnham EL; Ho PM; Allen RR; Vandivier RW; Moss M; Am J Respir Crit Care Med; 2018 Apr; 197(7):897-904. PubMed ID: 29241014 [TBL] [Abstract][Full Text] [Related]
10. Cisatracurium and atracurium as antigens. Fisher MM Anaesth Intensive Care; 1999 Aug; 27(4):369-70. PubMed ID: 10470390 [TBL] [Abstract][Full Text] [Related]
11. Neuromuscular Blockade Monitoring in Acute Respiratory Distress Syndrome: Randomized Controlled Trial of Clinical Assessment Alone or With Peripheral Nerve Stimulation. Rezaiguia-Delclaux S; Laverdure F; Genty T; Imbert A; Pilorge C; Amaru P; Sarfati C; Stéphan F Anesth Analg; 2021 Apr; 132(4):1051-1059. PubMed ID: 33002927 [TBL] [Abstract][Full Text] [Related]
12. Use of cisatracurium in critical care: a review of the literature. Szakmany T; Woodhouse T Minerva Anestesiol; 2015 Apr; 81(4):450-60. PubMed ID: 24721895 [TBL] [Abstract][Full Text] [Related]
13. The role of neuromuscular blockers in ARDS: benefits and risks. Hraiech S; Forel JM; Papazian L Curr Opin Crit Care; 2012 Oct; 18(5):495-502. PubMed ID: 22941207 [TBL] [Abstract][Full Text] [Related]
14. Cost analysis and safety comparison of Cisatracurium and Atracurium in patients undergoing general anesthesia. Movafegh A; Amini S; Sharifnia H; Torkamandi H; Hayatshahi A; Javadi M Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):447-50. PubMed ID: 23467941 [TBL] [Abstract][Full Text] [Related]
15. A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patients. Lagneau F; D'honneur G; Plaud B; Mantz J; Gillart T; Duvaldestin P; Marty J; Clyti N; Pourriat JL Intensive Care Med; 2002 Dec; 28(12):1735-41. PubMed ID: 12447516 [TBL] [Abstract][Full Text] [Related]
16. Compared efficacy and tolerance of the neuromuscular blockade induced by brand-name (Nimbex®) and generic (Cisatrex®) of cisatracurium in mechanically ventilated critically ill patients: a crossover double-blind randomized study. Fraj N; Meddeb K; Azouzi A; Romdhani S; Saad HB; Boussarsar M Pan Afr Med J; 2020; 37():346. PubMed ID: 33738034 [TBL] [Abstract][Full Text] [Related]
17. Cisatracurium dosing in a patient with hyperthermia. Lim J; Cox J; Nguyen T; Arya R Am J Health Syst Pharm; 2019 Jul; 76(14):1029-1032. PubMed ID: 31361873 [TBL] [Abstract][Full Text] [Related]
18. The shifting sands of mechanical ventilation. Hoyt JW Crit Care Med; 1998 Jul; 26(7):1162-3. PubMed ID: 9671363 [No Abstract] [Full Text] [Related]
19. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. ; Moss M; Huang DT; Brower RG; Ferguson ND; Ginde AA; Gong MN; Grissom CK; Gundel S; Hayden D; Hite RD; Hou PC; Hough CL; Iwashyna TJ; Khan A; Liu KD; Talmor D; Thompson BT; Ulysse CA; Yealy DM; Angus DC N Engl J Med; 2019 May; 380(21):1997-2008. PubMed ID: 31112383 [TBL] [Abstract][Full Text] [Related]
20. Heterotopic ossification due to neuromuscular blocking agent in adult respiratory distress syndrome. A case report. Zynnurodlu M; Kaymak Karatap G; Sepycy V Eur J Phys Rehabil Med; 2008 Mar; 44(1):81-5. PubMed ID: 18385631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]